Unknown

Dataset Information

0

ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.


ABSTRACT: Recessive loss-of-function mutations in ATP13A2 (PARK9) are associated with a spectrum of neurodegenerative disorders, including Parkinson's disease (PD). We recently revealed that the late endo-lysosomal transporter ATP13A2 pumps polyamines like spermine into the cytosol, whereas ATP13A2 dysfunction causes lysosomal polyamine accumulation and rupture. Here, we investigate how ATP13A2 provides protection against mitochondrial toxins such as rotenone, an environmental PD risk factor. Rotenone promoted mitochondrial-generated superoxide (MitoROS), which was exacerbated by ATP13A2 deficiency in SH-SY5Y cells and patient-derived fibroblasts, disturbing mitochondrial functionality and inducing toxicity and cell death. Moreover, ATP13A2 knockdown induced an ATF4-CHOP-dependent stress response following rotenone exposure. MitoROS and ATF4-CHOP were blocked by MitoTEMPO, a mitochondrial antioxidant, suggesting that the impact of ATP13A2 on MitoROS may relate to the antioxidant properties of spermine. Pharmacological inhibition of intracellular polyamine synthesis with ?-difluoromethylornithine (DFMO) also increased MitoROS and ATF4 when ATP13A2 was deficient. The polyamine transport activity of ATP13A2 was required for lowering rotenone/DFMO-induced MitoROS, whereas exogenous spermine quenched rotenone-induced MitoROS via ATP13A2. Interestingly, fluorescently labeled spermine uptake in the mitochondria dropped as a consequence of ATP13A2 transport deficiency. Our cellular observations were recapitulated in vivo, in a Caenorhabditis elegans strain deficient in the ATP13A2 ortholog catp-6 These animals exhibited a basal elevated MitoROS level, mitochondrial dysfunction, and enhanced stress response regulated by atfs-1, the C. elegans ortholog of ATF4, causing hypersensitivity to rotenone, which was reversible with MitoTEMPO. Together, our study reveals a conserved cell protective pathway that counters mitochondrial oxidative stress via ATP13A2-mediated lysosomal spermine export.

SUBMITTER: Vrijsen S 

PROVIDER: S-EPMC7733819 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.

Vrijsen Stephanie S   Besora-Casals Laura L   van Veen Sarah S   Zielich Jeffrey J   Van den Haute Chris C   Hamouda Norin Nabil NN   Fischer Christian C   Ghesquière Bart B   Tournev Ivailo I   Agostinis Patrizia P   Baekelandt Veerle V   Eggermont Jan J   Lambie Eric E   Martin Shaun S   Vangheluwe Peter P  

Proceedings of the National Academy of Sciences of the United States of America 20201123 49


Recessive loss-of-function mutations in <i>ATP13A2</i> (<i>PARK9</i>) are associated with a spectrum of neurodegenerative disorders, including Parkinson's disease (PD). We recently revealed that the late endo-lysosomal transporter ATP13A2 pumps polyamines like spermine into the cytosol, whereas ATP13A2 dysfunction causes lysosomal polyamine accumulation and rupture. Here, we investigate how ATP13A2 provides protection against mitochondrial toxins such as rotenone, an environmental PD risk factor  ...[more]

Similar Datasets

| S-EPMC3502545 | biostudies-literature
| S-EPMC3291101 | biostudies-literature
2012-07-16 | E-GEOD-39372 | biostudies-arrayexpress
| S-EPMC5077686 | biostudies-other
| S-EPMC1386026 | biostudies-other